Core Products
Home > Core Products
Lanreotide Acetate
US FDA DMF No.: 041446
Viwe More
Tirzepatide(under development)
US FDA DMF No.: 043257
Viwe More
Semaglutide(under development)
US FDA DMF No.: 043251
Viwe More
Retatrutide(under development)
Three-target GLP-1R/GCGR/GIPR
Viwe More
Pegcetacoplan(under development)
Viwe More
Albuvirtide(under development)
The world's first long-acting HIV fusion inhibitor. Commercial supply has been achieved.
Viwe More